You have watched someone you love try one antidepressant after another. The side effects compound the pain. The results do not come. For older adults with depression, this is not an unusual story; it is the norm.
Late-life depression affects approximately 6 million Americans aged 65 and older, according to the National Institute of Mental Health. Fewer than 10% receive treatment that actually works. The rest remain undertreated, often because standard medications are less effective in aging brains and carry real risks when combined with other prescriptions.
TMS therapy for seniors offers a clinically proven, drug-free alternative. At Iris TMS Wellness in Woodland Hills, California, Dr. Elena Kapustina, PsyD, supervises transcranial magnetic stimulation treatment specifically tailored to older adults, including those with treatment-resistant depression, medical comorbidities, and complex medication histories.
Medicare covers TMS for qualifying seniors. Our team verifies your benefits at no cost before any treatment begins.
No commitment required. Free, same-day response.
20300 Ventura Blvd, Suite 275
Medicare & Major Plans Accepted
Free In Building Lot
Free — No Obligation
Late-life depression is not the same as depression in younger adults. It is a distinct clinical condition with different causes, different presentations, and different treatment challenges.
Depression in older adults frequently develops alongside chronic physical illnesses. Cardiac disease, diabetes, high blood pressure, chronic pain, and neurological conditions all increase depression risk. This overlap makes late-life depression harder to recognize; symptoms are often misread as normal aging, grief, or physical illness alone.
The consequences of undertreated late-life depression are serious. Research published across geriatric psychiatry literature shows that depression in older adults:
Depression is not a normal part of aging. It is a medical condition. It responds to medical treatment, and for many older adults, TMS is the most effective treatment available.
Medicare Part B covers TMS therapy for seniors with treatment-resistant major depressive disorder. Our team handles prior authorization at no charge.
Antidepressants are the standard first line of treatment for depression. For younger adults, they produce meaningful results in many cases. For seniors, the picture is more complicated.
Most older adults are managing multiple medical conditions at once. The average senior takes four or more prescription medications daily. Adding an antidepressant introduces real risks: drug interactions, altered metabolism, increased fall risk from dizziness or sedation, and cardiac effects that can worsen existing heart conditions.
This is called polypharmacy risk, and it is one of the most significant clinical concerns in geriatric care.
Age-related changes in brain structure and blood flow affect how the brain responds to medication. Older adults typically show a slower antidepressant effect, requiring higher doses or longer trial periods to assess whether a medication is working. Higher doses bring more side effects. Longer trials mean more suffering.
In older adults, decreased blood flow to the prefrontal cortex, the region most responsible for mood regulation, reduces the brain’s ability to self-regulate. This is a structural and vascular issue that medication cannot directly address. Transcranial magnetic stimulation targets this region directly with focused magnetic pulses, bypassing the systemic limitations of antidepressants entirely.
Transcranial magnetic stimulation uses a focused electromagnetic coil placed against the scalp to deliver magnetic pulses to specific brain regions. In depression treatment, the primary target is the left dorsolateral prefrontal cortex, the area most consistently underactive in depressed patients.
The magnetic pulses stimulate nerve cells in this region, increasing neural activity and promoting more balanced mood regulation over repeated sessions. Unlike medication, TMS does not enter the bloodstream. It does not interact with other drugs. It does not sedate or alter alertness.
For older adults, this mechanism is particularly valuable because it directly stimulates the specific brain region affected by age-related vascular changes, without introducing systemic drug exposure.
Each TMS session at Iris TMS Wellness follows a consistent, comfortable process:
You sit in a reclined chair. No hospital gown. No IV. No preparation required.
The electromagnetic coil is positioned on the scalp above the left forehead. Positioning is measured carefully and recorded, so every session targets the same location.
Magnetic pulses are delivered in short bursts over 20 to 40 minutes. Most patients feel a light tapping or knocking on their scalp during treatment.
You stand up, gather your belongings, and drive yourself home. No recovery period. No monitoring required.
A standard TMS course consists of 30 to 36 sessions delivered five days per week over six to seven weeks.
Research published in peer-reviewed geriatric psychiatry literature, including a study highlighted by Hebrew SeniorLife and published in Frontiers in Aging Neuroscience, found that older adults may benefit from a longer treatment course than younger patients. Some seniors achieve their best outcomes with 36 or more sessions, as the aging brain responds more gradually to stimulation.
At Iris TMS Wellness, Dr. Kapustina monitors your progress throughout the course using structured symptom assessments. The personalized treatment plan is adjusted based on how you are responding.
Knowing exactly who is responsible for their care and being able to speak with that person directly.
Dr. Kapustina is available to every patient for clinical questions, progress conversations, and any concerns that arise during treatment.
Yes. TMS therapy has an established safety profile in older adult populations. It is FDA-cleared and has been studied specifically in geriatric patient groups.
One of the most common concerns families raise is whether TMS could affect memory or cognitive function in an older parent. This is a reasonable question, particularly for patients with mild cognitive impairment (MCI).
Clinical research does not show TMS to cause or worsen cognitive decline. In fact, some studies suggest that symptom reduction from TMS treatment is associated with improvements in cognitive performance because severe depression itself impairs concentration, memory, and executive function. Treating depression often improves these functions.
Dr. Kapustina reviews each patient’s cognitive history during the intake consultation. If there are specific concerns about cognitive status, she will discuss them openly before any treatment begins.
TMS is generally safe for seniors managing chronic medical conditions, including cardiac disease, diabetes, and high blood pressure. There are specific contraindications that would prevent treatment:
A pacemaker is not an automatic contraindication for TMS when the coil is positioned at the scalp, but this is evaluated case by case during your consultation.
TMS does not require anesthesia, sedation, or fasting. There is no impact on driving ability. The risks of TMS are significantly lower than those of electroconvulsive therapy (ECT), which requires general anesthesia and induces a controlled seizure.
Many seniors or their families have heard of ECT, often with concern. The comparison matters.
ECT requires general anesthesia. It induces a controlled seizure and is performed in a hospital setting. Patients need a recovery period and typically cannot drive for weeks during treatment. Memory disruption is a documented side effect.
TMS is entirely different. It is an outpatient procedure. It requires no anesthesia, no sedation, no seizure induction. Patients drive themselves to and from every session. Memory is not adversely affected.
Both treatments can be effective for severe, treatment-resistant depression. But for most older adults who qualify, TMS is a far less disruptive starting point – and for many, it produces durable results without the systemic burden of ECT.
Medicare Part B covers TMS therapy for older adults who meet specific clinical criteria. This is one of the most valuable and underused mental health benefits available to seniors in the San Fernando Valley.
At Iris TMS Wellness, we submit prior authorization requests on your behalf. Our team contacts Medicare before your first session to confirm what is covered, what your out-of-pocket cost will be, and whether any additional documentation is needed from your referring provider.
Out-of-pocket cost for a full TMS course without insurance ranges from $6,000 to $12,000. With Medicare coverage, most patients pay only their standard Part B deductible and coinsurance a fraction of the total cost.
We also accept Blue Shield of California, Anthem Blue Cross, Aetna, Cigna, Health Net, and additional commercial plans.
You or a family member may be a strong candidate for TMS treatment if:
If you are not sure whether TMS is appropriate, the consultation with Dr. Kapustina is the right starting point. There is no obligation to proceed with treatment after that conversation.
Iris TMS Wellness is located at 20300 Ventura Blvd, Suite 275, Woodland Hills, CA 91364. We serve patients traveling from across the western San Fernando Valley, including Tarzana, West Hills, Calabasas, Canoga Park, and Encino.
The clinic was built around focused specialty care. We do not treat every condition. We provide TMS and neurofeedback therapy under the direct oversight of Dr. Elena Kapustina, PsyD – a doctoral-level clinician who remains involved with each patient’s care throughout their full treatment course.
Seniors and their families consistently tell us that what matters most is knowing exactly who is responsible for their care – and being able to speak with that person directly. Dr. Kapustina is available to every patient for clinical questions, progress conversations, and any concerns that arise during treatment.
Free parking is available in the building lot. Sessions run 20 to 40 minutes. The clinic environment is calm, quiet, and designed to reduce procedural anxiety – particularly important for patients who may not have a prior history with specialty mental health care.
Yes. Medicare Part B covers TMS for major depressive disorder when patients have had an inadequate response to at least one antidepressant. We handle prior authorization at no charge.
Clinical research does not show TMS to cause or worsen cognitive decline. Patients with mild cognitive impairment have been included in TMS studies. Dr. Kapustina reviews cognitive history during the initial consultation and will advise if any concern applies to a specific patient’s situation.
Yes. TMS does not involve sedation or anesthesia. Patients drive themselves to and from every session.
A standard course is 30 to 36 sessions over six to seven weeks. Research specific to older adults suggests some patients may benefit from a longer course of up to 36 or more sessions, as the aging brain responds at a different pace.
Family members are welcome to accompany patients and wait in the reception area. If a patient finds the presence of a family member comforting, we accommodate that whenever practically possible.
A pacemaker is not always a contraindication for TMS, as the coil is positioned at the scalp away from the chest. This is evaluated individually during the consultation. Metallic implants in or near the head would prevent treatment.
It occurs alongside other illnesses more frequently, lasts longer, responds less well to standard antidepressants, and carries higher risk of serious outcomes including cardiac complications and suicide. It is a distinct clinical entity that warrants a targeted treatment approach.
Clinical research indicates TMS produces meaningful symptom reduction in 50 to 60% of older adults with treatment-resistant depression. Approximately 30 to 35% achieve full remission. Some studies in geriatric populations show TMS to be 2 to 3 times more effective than continued antidepressant trials.
No. TMS is not a drug and does not enter the bloodstream. It has no known interactions with cardiac medications, blood pressure drugs, diabetes medications, or any other common prescriptions seniors take.
Yes. Your first appointment at Iris TMS Wellness is a consultation with Dr. Kapustina. There is no charge and no treatment commitment.
Depression in older adults is serious. It is also treatable. TMS therapy for seniors offers a drug-free, Medicare-covered path forward for patients who have not found lasting relief with medication.
At Iris TMS Wellness in Woodland Hills, California, Dr. Elena Kapustina, PsyD brings both clinical precision and genuine personal care to every patient. Whether you are a senior researching your own options, or an adult child helping a parent find a way forward, we are glad to answer every question you have before you make any decision.
The consultation is free. Your Medicare benefits verification is free. There is no pressure and no obligation.
No commitment required. Free, same-day response.